Case Report: Safety and Efficacy of Denosumab in Four Children With Noonan Syndrome With Multiple Giant Cell Lesions of the Jaw
Noonan syndrome is a genetic disorder caused by mutations in the RAS/MAPK pathway. Multiple giant cell lesions are a rare sequelae of disruptions in this pathway, termed Noonan-like multiple giant cell lesions (NL/MGCLs). Medical management of these tumors rather than surgical intervention is prefer...
Main Authors: | Kristen Ferriero, Biraj Shah, Yun Yan, Surya Khatri, John Caccamese, Joseph A. Napoli, Michael B. Bober, Janet L. Crane |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fped.2020.00515/full |
Similar Items
-
DENOSUMAB-RELATED OSTEONECROSIS OF THE JAWS: A CASE REPORT
by: Milena Petkova, et al.
Published: (2017-03-01) -
Unilateral giant cell lesion of the jaw in Noonan syndrome
by: M Eyselbergs, et al.
Published: (2014-03-01) -
Efficiency of denosumab in giant cell tumor of the bone
by: N N Semenov
Published: (2013-06-01) -
A Retrospective Observational Study of Risk Factors for Denosumab-Related Osteonecrosis of the Jaw in Patients with Bone Metastases from Solid Cancers
by: Satoe Okuma, et al.
Published: (2020-05-01) -
Use of denosumab in recurrent giant cell tumour of bone: Report of two cases
by: Yuva Chandan Reddy J, et al.
Published: (2020-01-01)